Tiret L - Search Results

1

Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled.

Henry M, Aubert H, Morange PE, Nanni I, Alessi MC, Tiret L, Juhan-Vague I. Henry M, et al. Among authors: tiret l. Blood. 2001 Apr 1;97(7):2053-8. doi: 10.1182/blood.v97.7.2053. Blood. 2001. PMID: 11264171 Free article.

2

Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms.

Trégouet DA, Aubert H, Henry M, Morange P, Visvikis S, Juhan-Vague I, Tiret L. Trégouet DA, et al. Among authors: tiret l. Hum Genet. 2001 Aug;109(2):191-7. doi: 10.1007/s004390100558. Hum Genet. 2001. PMID: 11511925

3

TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study.

Morange PE, Tregouet DA, Frere C, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P, Cambien F, Tiret L, Juhan-Vague I; Prime Study Group. Morange PE, et al. Among authors: tiret l. J Thromb Haemost. 2005 Jul;3(7):1503-10. doi: 10.1111/j.1538-7836.2005.01486.x. J Thromb Haemost. 2005. PMID: 15978108 Free article.

4

Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort.

Henry M, Tregouët DA, Alessi MC, Aillaud MF, Visvikis S, Siest G, Tiret L, Juhan-Vague I. Henry M, et al. Among authors: tiret l. Arterioscler Thromb Vasc Biol. 1998 Jan;18(1):84-91. doi: 10.1161/01.atv.18.1.84. Arterioscler Thromb Vasc Biol. 1998. PMID: 9445260

5

Genetic polymorphisms and coronary artery disease in the south of France.

Canavy I, Henry M, Morange PE, Tiret L, Poirier O, Ebagosti A, Bory M, Juhan-Vague I. Canavy I, et al. Among authors: tiret l. Thromb Haemost. 2000 Feb;83(2):212-6. Thromb Haemost. 2000. PMID: 10739375

6

Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort.

Morange PE, Tregouet DA, Frere C, Saut N, Pellegrina L, Alessi MC, Visvikis S, Tiret L, Juhan-Vague I. Morange PE, et al. Among authors: tiret l. Br J Haematol. 2005 Jan;128(1):91-9. doi: 10.1111/j.1365-2141.2004.05275.x. Br J Haematol. 2005. PMID: 15606554 Free article.

7

Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.

Tregouet DA, Schnabel R, Alessi MC, Godefroy T, Declerck PJ, Nicaud V, Munzel T, Bickel C, Rupprecht HJ, Lubos E, Zeller T, Juhan-Vague I, Blankenberg S, Tiret L, Morange PE; AtheroGene Investigators. Tregouet DA, et al. Among authors: tiret l. J Thromb Haemost. 2009 Jan;7(1):49-57. doi: 10.1111/j.1538-7836.2008.03221.x. J Thromb Haemost. 2009. PMID: 19017260 Free article.

8

TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study.

Morange PE, Tiret L, Saut N, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P, Cambien F, Juhan-Vague I; PRIME Study Group. Morange PE, et al. Among authors: tiret l. Eur J Hum Genet. 2004 Dec;12(12):1041-9. doi: 10.1038/sj.ejhg.5201277. Eur J Hum Genet. 2004. PMID: 15367917

9

Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study.

Morange PE, Tregouet DA, Godefroy T, Saut N, Bickel C, Rupprecht HJ, Lackner K, Barbaux S, Poirier O, Peiretti F, Nalbone G, Juhan-Vague I, Blankenberg S, Tiret L. Morange PE, et al. Among authors: tiret l. J Mol Med (Berl). 2008 Oct;86(10):1153-61. doi: 10.1007/s00109-008-0375-6. Epub 2008 Jul 4. J Mol Med (Berl). 2008. PMID: 18600307

10

Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study.

Morange PE, Blankenberg S, Alessi MC, Bickel C, Rupprecht HJ, Schnabel R, Lubos E, Münzel T, Peetz D, Nicaud V, Juhan-Vague I, Tiret L; Atherogene Investigators. Morange PE, et al. Among authors: tiret l. J Thromb Haemost. 2007 Mar;5(3):475-82. doi: 10.1111/j.1538-7836.2007.02372.x. Epub 2007 Jan 4. J Thromb Haemost. 2007. PMID: 17204132 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

277 results

Search Page